Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: Data from the ACTG A5175/PEARLS trial

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Safren, Steven A ^a,b,c   Biello, Katie B ^c,d   Smeaton, Laura ^d   Mimiaga, Matthew J ^a,b,c,d   Walawander, Ann ^e   Lama, Javier R ^f   Rana, Aadia ^g   Nyirenda, Mulinda ^h   Kayoyo, Virginia M ⁱ   Samaneka, Wadzanai ^j   Joglekar, Anjali ^k   Celentano, David ^l   Martinez, Ana ^m   Remmert, Jocelyn E ^a   Nair, Aspara ^e   Lalloo, Umesh G ⁿ   Kumarasamy, Nagalingeswaran ^o   Hakim, James ^j   Campbell, Thomas B ^p  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c FENWAY INSTITUTE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^f ASOCIACIÓN CIVIL IMPACTA SALUD Y EDUCACIÓN   (Peru)

^g MIRIAM HOSPITAL   (United States)

^h UNIVERSITY OF MALAWI   (Malawi)

ⁱ UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^j UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^k NATIONAL AIDS RESEARCH INSTITUTE   (India)

^l JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^m NATIONAL INSTITUTES OF HEALTH   (United States)

ⁿ UNIVERSITY OF KWAZULU NATAL   (South Africa)

^o VHS Medical Centre India   (India)

^p UNIVERSITY OF COLORADO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE PLUS ZIDOVUDINE; ANTIRETROVIRUS AGENT;

ADULT; AFRICA; AGE DISTRIBUTION; ARTICLE; ASIA; BINGE DRINKING; COMORBIDITY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MENTAL HEALTH; MULTICENTER STUDY (TOPIC); OPEN STUDY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT TRANSPORT; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; SEXUAL BEHAVIOR; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SUBSTANCE USE; TIME TO TREATMENT FAILURE; TREATMENT REFUSAL; UNPROTECTED SEX; CONTROLLED STUDY; HIV INFECTIONS; MIDDLE AGED; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; THEORETICAL MODEL; TREATMENT OUTCOME;

ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PATIENT COMPLIANCE; PSYCHOLOGY; QUALITY OF LIFE; SOCIAL SUPPORT; TREATMENT OUTCOME;

EID: 84910629794     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104178     Document Type: Article

References (22)

1. Bämighausen T (2007) Access to antiretroviral treatment in the developing world: a framework, review and health systems research agenda. Therapy 4: 753-766.
2. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493-505. doi:10.1056/NEJMoa1105243.
3. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, et al. (2006) Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 3: e438. doi:10.1371/journal.pmed.0030438.
4. Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, et al. (2009) Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med 6: e11. doi:10.1371/journal.pmed.1000011.
5. Kunutsor S, Evans M, Thoulass J, Walley J, Katabira E, et al. (2010) Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: a multimethod approach. J Acquir Immune Defic Syndr 1999 55: 221-224. doi:10.1097/QAI.0b013e3181e255ec.
6. Nsimba SE, Irunde H, Comoro C (2010) Barriers to ARV Adherence among HIV/AIDS Positive Persons taking Anti-Retroviral Therapy in Two Tanzanian Regions 8-12 Months after Program Initiation. J AIDS Clin Res 1.
7. Reda AA, Biadgilign S (2012) Determinants of Adherence to Antiretroviral Therapy among HIV-Infected Patients in Africa. AIDS Res Treat 2012: 574656. doi:10.1155/2012/574656.
8. Malow R, Dévieux JG, Stein JA, Rosenberg R, Jean-Gilles M, et al. (2013) Depression, substance abuse and other contextual predictors of adherence to antiretroviral therapy (ART) among Haitians. AIDS Behav 17: 1221-1230. doi:10.1007/s10461-012-0400-1.
9. O'Connor JL, Gardner EM, Mannheimer SB, Lifson AR, Esser S, et al. (2013) Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trial. J Infect Dis 208: 40-49. doi:10.1093/infdis/jis731.
10. Sabin LL, Desilva MB, Hamer DH, Keyi X, Yue Y, et al. (2008) Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: a qualitative study. AIDS Care 20: 1242-1250. doi:10.1080/09540120801918651.
11. Wasti SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E (2012) Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PloS One 7: e35547. doi:10.1371/journal.pone.0035547.
12. Campbell TB, Smeaton LM, Kumarasamy N, Flanigan T, Klingman KL, et al. (2012) Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. PLoS Med 9: e1001290. doi:10.1371/journal.pmed.1001290.
13. Bärnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, et al. (2011) Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis 11: 942-951. doi:10.1016/S1473-3099(11)70181-5.
14. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, et al. (2000) Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 12: 255-266. doi:10.1080/09540120050042891. (Pubitemid 30426745)
15. Safren SA, Hendriksen ES, Smeaton L, Celentano DD, Hosseinipour MC, et al. (2012) Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world. AIDS Behav 16: 266-277. doi:10.1007/s10461-011-9947-5.
16. Wu AW, Huang IC, Gifford AL, Spritzer KL, Bozzette SA, et al. (2005) Creating a crosswalk to estimate AIDS Clinical Trials Group quality of life scores in a nationally representative sample of persons in care for HIV in the United States. HIV Clin Trials 6: 147-157. doi:10.1310/BPNB-XELF-AXFQ-QQTL. (Pubitemid 41341729)
17. ACTG (1999) ACTG QOL 601-602 (QOL 601-2) Health Survey Manual. Available: https://www.fstrf.org/apps/cfmx/apps/common/QOLAdherenceForms/resources/actg/ manualql601-2799.pdf.
18. Reynolds NR, Sun J, Nagaraja HN, Gifford AL, Wu AW, et al. (2007) Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysis. J Acquir Immune Defic Syndr 1999 46: 402-409. (Pubitemid 350098690)
19. Kaiser HF (1960) The application of electronic computers to factor analysis. Educ Psychol Meas 20: 141-151.
20. Cattell RB (1966) The screen test for the number of factors. Multivar Behav Res 1.
21. Adakun SA, Siedner MJ, Muzoora C, Haberer JE, Tsai AC, et al. (2013) Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda. J Acquir Immune Defic Syndr 1999 62: 317-321. doi:10.1097/QAI.0b013e3182800daf.
22. Fogarty L, Roter D, Larson S, Burke J, Gillespie J, et al. (2002) Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns 46: 93-108. (Pubitemid 34175086)